Manufacturing and Production

Showing 15 posts of 5863 posts found.

ianreadweb

Ian Read elected as chairman of the board at Pfizer

December 13, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Kindler, Pfizer

Pfizer’s chief executive and president Ian Read has been elected as the firm’s new chairman. Read succeeds George Lorch as …
Pfizer picture

Pfizer awaits verdict on contaminated site clean-up plan

December 13, 2011 Manufacturing and Production, Sales and Marketing FDA, Pfizer, manufacturing

The US Environmental Protection Agency is due to deliver a verdict on a $205 million proposal by Pfizer to clean …
Jim Easton picture

Who’s really in charge of the new NHS?

December 12, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS reform

Each year the health service, the Department of Health and the UK pharmaceutical industry get an opportunity to say what …
EMA picture

EMA and FDA move closer on inspections

December 12, 2011 Manufacturing and Production EMA, FDA

The EMA and US FDA has taken a step closer to mutual recognition of manufacturing site inspections, launching a three-year …

SHL receives great response at the 2011 PDA in Basel

December 12, 2011 Manufacturing and Production autoinjector, pda, pen injector, prefilled syringe, shl group

SHL successfully wrapped up this year’s exhibition at the PDA’s ” The Universe of Pre-filled Syringes and Injection Devices” 2011 …

Dechra Pharmaceuticals PLC FDA Approval for manufacturing at Dales Pharmaceuticals

December 9, 2011 Manufacturing and Production, Research and Development FDA Approval

Dechra® Pharmaceuticals PLCFDA APPROVAL FOR MANUFACTURING AT DALES® PHARMACEUTICALS  Dales Pharmaceuticals (‘Dales’ or the ‘Company’), based in Skipton, North Yorkshire, UK, …
Novartis' facility in North Carolina

Novartis warned over standards at generics sites

December 9, 2011 Manufacturing and Production CGMP Failures, FDA compliance, Novartis, Sandoz

The FDA has warned Novartis that three North American production facilities operated by its generics subsidiary Sandoz are failing to …

Dr Rajeev Venkayya to head Takeda’s new vaccine business

December 9, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda

Takeda will establish a new vaccine business division in January next year and will appoint Dr Rajeev Venkayya as its …

Deepak Khanna becomes new ABPI president-elect

December 8, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna

Deepak Khanna, senior vice president and UK managing director of Merck, Sharp and Dohme has been named as president-elect of …

Biogen and Samsung invest $300m on joint biosimilars venture

December 8, 2011 Manufacturing and Production Biogen, Samsung, biosimilars

Biogen Idec and Samsung will invest $300 million in a joint venture to develop biosimilars. Both firms will contribute a …

New EU Cosmetics Regulation

December 7, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The European Cosmetics Directive has been recast and the new legislation takes the form of Regulation 1223/2009.  As a Regulation, …
Lonza picture

Lonza to make Elan’s Alzheimer’s candidate

December 7, 2011 Manufacturing and Production Abbott, Elan, Lonza

Elan has awarded a manufacturing contract to Lonza to supply the active pharmaceutical ingredient (API) for its small-molecule candidate Alzheimer’s …

Contract research news in brief

December 7, 2011 Manufacturing and Production Almac, GVK Biosciences and PreClinOmics/AIT, PPD, Quintiles

Our round-up of news from the contract research sector includes PPD’s sales to a private equity consortium, new clinical supply …

Catalent Announces plans to increase Biologic Development and Manufacturing Capabilities

December 7, 2011 Manufacturing and Production

SOMERSET, NJ, December 7, 2011 — Catalent Pharma Solutions, a leading provider of drug and biologic development services, delivery technologies …

Health Protection Agency welcomes the Approval of ERWINAZE™ Biologics License Application for Treatment of Acute Lymphoblastic Leukemia

December 7, 2011 Manufacturing and Production

Salisbury, UK – 18th November 2011 –the Health Protection Agency (HPA) today welcomed the news that the U.S. Food and …
The Gateway to Local Adoption Series

Latest content